Regulaxis is proud to announce to receive € 2.1m from EU Horizon 2020 SME instrument Phase 2 program for early gonarthrosis (OA) therapeutic drug regenerating cartilage !
Prize
Awarding a European prize is equivalent to a validation of the Technology readiness level (TRL) of the project by an independent body (EASME).
2017 H2020 SME INSTRUMENT phase-2 Topic :SMEInst-03-2017. European commission
2015 H2020 SME INSTRUMENT phase-1 Topic : BIOTEC-5a2015. European commission
2015 17th i-Lab “Créadev” BPI France
2013 15th “émergence” OSEO/BPI
2013 – Innovation Days One of 15 finalists “Innovation Prize” Universal Biotech.
Leave A Comment